No Data
No Data
Lanwei Medical (301060.SZ): The shares issued before the initial public offering of 0.217 billion shares will be unlocked on September 13.
Gelonghui September 9th | Lanwei Medicine (301060.SZ) announced a preliminary announcement of the first public issuance of shares that had been issued and listed for circulation. The number of shares to be released from restrictions and listed for circulation this time is 0.217 billion shares, accounting for 54.10% of the total share capital of the company, with a lock-up period of 36 months from the date of the company's first public offering and listing. The date of release of the restricted shares for listing and circulation is September 13, 2024 (Friday).
Lan Wei Medical (301060.SZ): has repurchased a total of 1.6402 million shares.
On September 3, Gelunhui announced that as of August 31, 2024, the company has repurchased a total of 1.6402 million shares of the company through the stock trading system of the Shenzhen Stock Exchange in a centralized competitive bidding trading manner, accounting for 0.41% of the current total share capital of the company. The highest fill price was 14.23 yuan/share, the lowest fill price was 8.12 yuan/share, and the total fill amount was RMB 19.3995 million (excluding transaction costs).
Lanwei Medical: 2024 Semi-Annual Report Summary
Lanwei Medical: 2024 Semi-Annual Report
Lanwei Medical (301060.SZ): Net income in the first half of the year was 15.5976 million yuan, a turnaround from the same period last year.
Gelonghui, August 27th | Lanwei Medical (301060.SZ) released the 2024 interim report, with a half-year revenue of 0.888 billion yuan, a year-on-year growth of 6.00%; the net income attributable to shareholders of the listed company was 15.5976 million yuan, turning losses into profits year-on-year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 10.9121 million yuan; the basic earnings per share was 0.0389 yuan.
There is a risk of diffusion! WHO has launched a global strategic preparedness, and monkeypox concept stocks have surged in response.
New variant appears.
No Data
No Data